Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron.
D000928:Antidepressive Agents / Q000009:adverse effects* / Q000494:pharmacology; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003863:Depression / Q000150:complications / Q000188:drug therapy; D004347:Drug Interactions; D004562:Electrocardiography; D006145:Guanethidine / Q000494:pharmacology; D006331:Heart Diseases / Q000139:chemically induced / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D009638:Norepinephrine / Q000378:metabolism* / Q000502:physiology; D010640:Phenothiazines / Q000009:adverse effects; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism; D013566:Sympathomimetics / Q000494:pharmacology
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D013566:Sympathomimetics; D012110:Reserpine; D008995:Monoamine Oxidase; D009638:Norepinephrine; D006145:Guanethidine